Dicerna Pharmaceuticals, Inc. (NASDAQ: DRNA), a leader in the
development of RNAi-based therapeutics, today announced that Douglas M.
Fambrough, PhD, the Company's President and CEO, is scheduled to present
at the 21st Annual Future Leaders in the Biotech Industry
conference on Friday, March 28, 2014 at 2:00 PM ET in New York, NY.
A live webcast will be available at this
link or can be accessed by visiting "Events & Presentations" in the
Investors and Media section of the Company's website at www.dicerna.com.
An archived replay of the webcast will be available on the Company's
website after the conference.
About Dicerna Pharmaceuticals, Inc.
Dicerna is a biopharmaceutical company focused on the discovery and
development of innovative treatments for rare inherited diseases
involving the liver and for cancers that are genetically defined.
Dicerna is using its proprietary RNA interference (RNAi) technology
platform to build a broad pipeline in these therapeutic areas and
intends to discover, develop and commercialize novel therapeutics either
on its own or in collaboration with pharmaceutical partners.
[ Back To NFVZone's Homepage ]